Literature DB >> 11117527

Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators.

G Lazennec1, L Canaple, D Saugy, W Wahli.   

Abstract

The nuclear peroxisome proliferator-activated receptors (PPARs) alpha, beta, and gamma activate the transcription of multiple genes involved in lipid metabolism. Several natural and synthetic ligands have been identified for each PPAR isotype but little is known about the phosphorylation state of these receptors. We show here that activators of protein kinase A (PKA) can enhance mouse PPAR activity in the absence and the presence of exogenous ligands in transient transfection experiments. Activation function 1 (AF-1) of PPARs was dispensable for transcriptional enhancement, whereas activation function 2 (AF-2) was required for this effect. We also show that several domains of PPAR can be phosphorylated by PKA in vitro. Moreover, gel retardation experiments suggest that PKA stabilizes binding of the liganded PPAR to DNA. PKA inhibitors decreased not only the kinase-dependent induction of PPARs but also their ligand-dependent induction, suggesting an interaction between both pathways that leads to maximal transcriptional induction by PPARs. Moreover, comparing PPAR alpha knockout (KO) with PPAR alpha WT mice, we show that the expression of the acyl CoA oxidase (ACO) gene can be regulated by PKA-activated PPAR alpha in liver. These data demonstrate that the PKA pathway is an important modulator of PPAR activity, and we propose a model associating this pathway in the control of fatty acid beta-oxidation under conditions of fasting, stress, and exercise.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11117527      PMCID: PMC2040490          DOI: 10.1210/mend.14.12.0575

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  57 in total

1.  Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors.

Authors:  C Dreyer; G Krey; H Keller; F Givel; G Helftenbein; W Wahli
Journal:  Cell       Date:  1992-03-06       Impact factor: 41.582

2.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.

Authors:  I Issemann; S Green
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

3.  Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription.

Authors:  S M Aronica; W L Kraus; B S Katzenellenbogen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

4.  Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.

Authors:  T Chijiwa; A Mishima; M Hagiwara; M Sano; K Hayashi; T Inoue; K Naito; T Toshioka; H Hidaka
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

5.  Progesterone receptor regulation in uterine cells: stimulation by estrogen, cyclic adenosine 3',5'-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors.

Authors:  S M Aronica; B S Katzenellenbogen
Journal:  Endocrinology       Date:  1991-04       Impact factor: 4.736

6.  Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.

Authors:  H Cho; B S Katzenellenbogen
Journal:  Mol Endocrinol       Date:  1993-03

7.  Modulation of glucocorticoid receptor function by protein kinase A.

Authors:  P N Rangarajan; K Umesono; R M Evans
Journal:  Mol Endocrinol       Date:  1992-09

8.  Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: antiestrogen selectivity and promoter dependence.

Authors:  N Fujimoto; B S Katzenellenbogen
Journal:  Mol Endocrinol       Date:  1994-03

9.  Control of fructose 2,6-diphosphate in muscle of exercising fasted rats.

Authors:  W W Winder; C Duan
Journal:  Am J Physiol       Date:  1992-06

10.  Role of cAMP in mediating effects of fasting on dephosphorylation of insulin receptor.

Authors:  N Begum; A L Graham; K E Sussman; B Draznin
Journal:  Am J Physiol       Date:  1992-02
View more
  60 in total

1.  IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1.

Authors:  A C Bendixen; N K Shevde; K M Dienger; T M Willson; C D Funk; J W Pike
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

Review 2.  Crosstalk of oncogenic and prostanoid signaling pathways.

Authors:  Rolf Müller
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-15       Impact factor: 4.553

Review 3.  Vascular effects of prostacyclin: does activation of PPARδ play a role?

Authors:  Zvonimir S Katusic; Anantha V Santhanam; Tongrong He
Journal:  Trends Pharmacol Sci       Date:  2012-06-23       Impact factor: 14.819

4.  A role of PPAR-gamma in androstenediol-mediated salutary effects on cardiac function following trauma-hemorrhage.

Authors:  Tomoharu Shimizu; László Szalay; Ya-Ching Hsieh; Takao Suzuki; Mashkoor A Choudhry; Kirby I Bland; Irshad H Chaudry
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

Review 5.  The complications of promiscuity: endocannabinoid action and metabolism.

Authors:  S P H Alexander; D A Kendall
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

Review 6.  Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease.

Authors:  Jeff L Staudinger; Kristin Lichti
Journal:  Mol Pharm       Date:  2007-12-27       Impact factor: 4.939

7.  Expression of apolipoprotein C-IV is regulated by Ku antigen/peroxisome proliferator-activated receptor gamma complex and correlates with liver steatosis.

Authors:  Eun Kim; Ke Li; Charmiane Lieu; Shuping Tong; Shigenobu Kawai; Takayoshi Fukutomi; Yonghong Zhou; Jack Wands; Jisu Li
Journal:  J Hepatol       Date:  2008-09-07       Impact factor: 25.083

8.  The molecular and metabolic influence of long term agmatine consumption.

Authors:  Itzhak Nissim; Oksana Horyn; Yevgeny Daikhin; Pan Chen; Changhong Li; Suzanne L Wehrli; Ilana Nissim; Marc Yudkoff
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

Review 9.  Genetic-dependency of peroxisomal cell functions - emerging aspects.

Authors:  N Latruffe; J Vamecq; M Cherkaoui Malki
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310

10.  PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer.

Authors:  A Belfiore; M Genua; R Malaguarnera
Journal:  PPAR Res       Date:  2009-07-07       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.